OAKLANDS MEDICAL LIMITEDActive

Company number 09259596Private limited companyIncorporated 2014

Key figures

£183,038+39.1%
Net assets 2024/25
+102.1%
Average annual growth 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222023/242024/25

Like most small UK companies, OAKLANDS MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222023/242024/25

Dividends

from the accounts
2020/21

Dividends paid in the financial year: £38,000 (101% of the profit for the year).

Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Profit for the year—37,483———
Cash at bank and in hand—71,935———
Total assets64,18587,000128,533209,700258,902
Total liabilities51,67676,550———
Net assets / total equity10,96710,45055,541131,595183,038
Average number of employees11211
Dividends paid—38,000———

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: OAKLANDS MEDICAL LIMITED

Company

OAKLANDS MEDICAL LIMITED is a private limited company registered with Companies House under company number 09259596. It was incorporated on 13 Oct 2014. Its status is active. The registered office is in Billingham (TS22). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were £183,038, up 39.1% on the previous year. The company had an average of 1 employee. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 27 Nov 2026.